The global Sumatriptan Succinate Tablets market was valued at US$ 255 million in 2025 and is anticipated to reach US$ 324 million by 2032, at a CAGR of 3.7% from 2026 to 2032.

Sumatriptan Succinate Tablets Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Sumatriptan Succinate Tablets competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.

Sumatriptan succinate tablets are oral solid formulations within the triptan class for the acute treatment of migraine, commonly available in strengths of 25 mg, 50 mg, and 100 mg, and primarily indicated for the relief of acute migraine attacks in adults. Upstream raw materials mainly include sumatriptan succinate active pharmaceutical ingredient (API), standard oral solid excipients such as microcrystalline cellulose, lactose or anhydrous dicalcium phosphate, crospovidone, hypromellose, and magnesium stearate, as well as pharmaceutical packaging materials including aluminum–plastic blisters or bottles. The manufacturing process involves standardized granulation, compression, coating, and quality control procedures. Downstream customers include global and regional generic drug manufacturers, hospital procurement systems, retail pharmacy chains, and e-prescription platforms. On a manufacturing ex-factory basis, global nominal production capacity in 2025 is estimated at approximately 350 million tablets, with actual sales of about 286 million tablets and a weighted average ex-factory price of around USD 0.89 per tablet; under competitive generic market conditions and centralized procurement pressure, manufacturing-level gross margin typically ranges from 28% to 38%.

The North American market for Sumatriptan Succinate Tablets is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

The Asia-Pacific market for Sumatriptan Succinate Tablets is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

Major global manufacturers of Sumatriptan Succinate Tablets include Dr Reddy's Laboratories, Aurobindo Pharma, Teva Pharmaceutical Industries, Viatris, GlaxoSmithKline, Sun Pharmaceutical Industries, Simcere Pharmaceutical, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.

This report delivers a comprehensive overview of the global Sumatriptan Succinate Tablets market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Sumatriptan Succinate Tablets. The Sumatriptan Succinate Tablets market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Sumatriptan Succinate Tablets market comprehensively. Regional market sizes by Type, by Application, by Regulatory Status, and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Sumatriptan Succinate Tablets manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Sumatriptan Succinate Tablets Market Report

Report Metric	Details
Report Name	Sumatriptan Succinate Tablets Market
Accounted market size in 2025	US$ 255 million
Forecasted market size in 2032	US$ 324 million
CAGR	3.7%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	25 mg 50 mg 100 mg
Segment by Regulatory Status	Originator Product Generic Product
by Application	Hospital Clinic Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Dr Reddy's Laboratories, Aurobindo Pharma, Teva Pharmaceutical Industries, Viatris, GlaxoSmithKline, Sun Pharmaceutical Industries, Simcere Pharmaceutical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Regulatory Status, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Sumatriptan Succinate Tablets manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Sumatriptan Succinate Tablets sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Sumatriptan Succinate Tablets Market growing?

Ans: The Sumatriptan Succinate Tablets Market witnessing a CAGR of 3.7% during the forecast period 2026-2032.

What is the Sumatriptan Succinate Tablets Market size in 2032?

Ans: The Sumatriptan Succinate Tablets Market size in 2032 will be US$ 324 million.

Who are the main players in the Sumatriptan Succinate Tablets Market report?

Ans: The main players in the Sumatriptan Succinate Tablets Market are Dr Reddy's Laboratories, Aurobindo Pharma, Teva Pharmaceutical Industries, Viatris, GlaxoSmithKline, Sun Pharmaceutical Industries, Simcere Pharmaceutical

What are the Application segmentation covered in the Sumatriptan Succinate Tablets Market report?

Ans: The Applications covered in the Sumatriptan Succinate Tablets Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the Sumatriptan Succinate Tablets Market report?

Ans: The Types covered in the Sumatriptan Succinate Tablets Market report are 25 mg, 50 mg, 100 mg

1 Sumatriptan Succinate Tablets Market Overview

1.1 Product Definition

1.2 Sumatriptan Succinate Tablets by Type

1.2.1 Global Sumatriptan Succinate Tablets Market Value by Type: 2025 vs 2032

1.2.2 25 mg

1.2.3 50 mg

1.2.4 100 mg

1.3 Sumatriptan Succinate Tablets by Regulatory Status

1.3.1 Global Sumatriptan Succinate Tablets Market Value by Regulatory Status: 2025 vs 2032

1.3.2 Originator Product

1.3.3 Generic Product

1.4 Sumatriptan Succinate Tablets by Application

1.4.1 Global Sumatriptan Succinate Tablets Market Value by Application: 2025 vs 2032

1.4.2 Hospital

1.4.3 Clinic

1.4.4 Others

1.5 Global Sumatriptan Succinate Tablets Market Size Estimates and Forecasts

1.5.1 Global Sumatriptan Succinate Tablets Revenue 2021–2032

1.5.2 Global Sumatriptan Succinate Tablets Sales 2021–2032

1.5.3 Global Sumatriptan Succinate Tablets Market Average Price (2021–2032)

1.6 Assumptions and Limitations

2 Sumatriptan Succinate Tablets Market Competition by Manufacturers

2.1 Global Sumatriptan Succinate Tablets Sales Market Share by Manufacturers (2021–2026)

2.2 Global Sumatriptan Succinate Tablets Revenue Market Share by Manufacturers (2021–2026)

2.3 Global Sumatriptan Succinate Tablets Average Price by Manufacturers (2021–2026)

2.4 Global Key Players of Sumatriptan Succinate Tablets, Industry Ranking, 2023 vs 2024 vs 2025

2.5 Global Key Manufacturers of Sumatriptan Succinate Tablets, Manufacturing Sites and Headquarters

2.6 Global Key Manufacturers of Sumatriptan Succinate Tablets, Product Types and Applications

2.7 Global Key Manufacturers of Sumatriptan Succinate Tablets, Date of Entry into the Industry

2.8 Global Sumatriptan Succinate Tablets Market Competitive Situation and Trends

2.8.1 Global Sumatriptan Succinate Tablets Market Concentration Rate

2.8.2 The Top 5 and Top 10 Global Sumatriptan Succinate Tablets Players Market Share by Revenue

2.8.3 Global Sumatriptan Succinate Tablets Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Sumatriptan Succinate Tablets Market Scenario by Region

3.1 Global Sumatriptan Succinate Tablets Market Size by Region: 2021 vs 2025 vs 2032

3.2 Global Sumatriptan Succinate Tablets Sales by Region: 2021–2032

3.2.1 Global Sumatriptan Succinate Tablets Sales by Region: 2021–2026

3.2.2 Global Sumatriptan Succinate Tablets Sales by Region: 2027–2032

3.3 Global Sumatriptan Succinate Tablets Revenue by Region: 2021–2032

3.3.1 Global Sumatriptan Succinate Tablets Revenue by Region: 2021–2026

3.3.2 Global Sumatriptan Succinate Tablets Revenue by Region: 2027–2032

3.4 North America Sumatriptan Succinate Tablets Market Facts & Figures by Country

3.4.1 North America Sumatriptan Succinate Tablets Market Size by Country: 2021 vs 2025 vs 2032

3.4.2 North America Sumatriptan Succinate Tablets Sales by Country (2021–2032)

3.4.3 North America Sumatriptan Succinate Tablets Revenue by Country (2021–2032)

3.4.4 United States

3.4.5 Canada

3.5 Europe Sumatriptan Succinate Tablets Market Facts & Figures by Country

3.5.1 Europe Sumatriptan Succinate Tablets Market Size by Country: 2021 vs 2025 vs 2032

3.5.2 Europe Sumatriptan Succinate Tablets Sales by Country (2021–2032)

3.5.3 Europe Sumatriptan Succinate Tablets Revenue by Country (2021–2032)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Sumatriptan Succinate Tablets Market Facts & Figures by Region

3.6.1 Asia Pacific Sumatriptan Succinate Tablets Market Size by Region: 2021 vs 2025 vs 2032

3.6.2 Asia Pacific Sumatriptan Succinate Tablets Sales by Region (2021–2032)

3.6.3 Asia Pacific Sumatriptan Succinate Tablets Revenue by Region (2021–2032)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Sumatriptan Succinate Tablets Market Facts & Figures by Country

3.7.1 Latin America Sumatriptan Succinate Tablets Market Size by Country: 2021 vs 2025 vs 2032

3.7.2 Latin America Sumatriptan Succinate Tablets Sales by Country (2021–2032)

3.7.3 Latin America Sumatriptan Succinate Tablets Revenue by Country (2021–2032)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa Sumatriptan Succinate Tablets Market Facts & Figures by Country

3.8.1 Middle East and Africa Sumatriptan Succinate Tablets Market Size by Country: 2021 vs 2025 vs 2032

3.8.2 Middle East and Africa Sumatriptan Succinate Tablets Sales by Country (2021–2032)

3.8.3 Middle East and Africa Sumatriptan Succinate Tablets Revenue by Country (2021–2032)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Sumatriptan Succinate Tablets Sales by Type (2021–2032)

4.1.1 Global Sumatriptan Succinate Tablets Sales by Type (2021–2026)

4.1.2 Global Sumatriptan Succinate Tablets Sales by Type (2027–2032)

4.1.3 Global Sumatriptan Succinate Tablets Sales Market Share by Type (2021–2032)

4.2 Global Sumatriptan Succinate Tablets Revenue by Type (2021–2032)

4.2.1 Global Sumatriptan Succinate Tablets Revenue by Type (2021–2026)

4.2.2 Global Sumatriptan Succinate Tablets Revenue by Type (2027–2032)

4.2.3 Global Sumatriptan Succinate Tablets Revenue Market Share by Type (2021–2032)

4.3 Global Sumatriptan Succinate Tablets Price by Type (2021–2032)

5 Segment by Application

5.1 Global Sumatriptan Succinate Tablets Sales by Application (2021–2032)

5.1.1 Global Sumatriptan Succinate Tablets Sales by Application (2021–2026)

5.1.2 Global Sumatriptan Succinate Tablets Sales by Application (2027–2032)

5.1.3 Global Sumatriptan Succinate Tablets Sales Market Share by Application (2021–2032)

5.2 Global Sumatriptan Succinate Tablets Revenue by Application (2021–2032)

5.2.1 Global Sumatriptan Succinate Tablets Revenue by Application (2021–2026)

5.2.2 Global Sumatriptan Succinate Tablets Revenue by Application (2027–2032)

5.2.3 Global Sumatriptan Succinate Tablets Revenue Market Share by Application (2021–2032)

5.3 Global Sumatriptan Succinate Tablets Price by Application (2021–2032)

6 Key Companies Profiled

6.1 Dr Reddy's Laboratories

6.1.1 Dr Reddy's Laboratories Company Information

6.1.2 Dr Reddy's Laboratories Description and Business Overview

6.1.3 Dr Reddy's Laboratories Sumatriptan Succinate Tablets Sales, Revenue, and Gross Margin (2021–2026)

6.1.4 Dr Reddy's Laboratories Sumatriptan Succinate Tablets Product Portfolio

6.1.5 Dr Reddy's Laboratories Recent Developments/Updates

6.2 Aurobindo Pharma

6.2.1 Aurobindo Pharma Company Information

6.2.2 Aurobindo Pharma Description and Business Overview

6.2.3 Aurobindo Pharma Sumatriptan Succinate Tablets Sales, Revenue, and Gross Margin (2021–2026)

6.2.4 Aurobindo Pharma Sumatriptan Succinate Tablets Product Portfolio

6.2.5 Aurobindo Pharma Recent Developments/Updates

6.3 Teva Pharmaceutical Industries

6.3.1 Teva Pharmaceutical Industries Company Information

6.3.2 Teva Pharmaceutical Industries Description and Business Overview

6.3.3 Teva Pharmaceutical Industries Sumatriptan Succinate Tablets Sales, Revenue, and Gross Margin (2021–2026)

6.3.4 Teva Pharmaceutical Industries Sumatriptan Succinate Tablets Product Portfolio

6.3.5 Teva Pharmaceutical Industries Recent Developments/Updates

6.4 Viatris

6.4.1 Viatris Company Information

6.4.2 Viatris Description and Business Overview

6.4.3 Viatris Sumatriptan Succinate Tablets Sales, Revenue, and Gross Margin (2021–2026)

6.4.4 Viatris Sumatriptan Succinate Tablets Product Portfolio

6.4.5 Viatris Recent Developments/Updates

6.5 GlaxoSmithKline

6.5.1 GlaxoSmithKline Company Information

6.5.2 GlaxoSmithKline Description and Business Overview

6.5.3 GlaxoSmithKline Sumatriptan Succinate Tablets Sales, Revenue, and Gross Margin (2021–2026)

6.5.4 GlaxoSmithKline Sumatriptan Succinate Tablets Product Portfolio

6.5.5 GlaxoSmithKline Recent Developments/Updates

6.6 Sun Pharmaceutical Industries

6.6.1 Sun Pharmaceutical Industries Company Information

6.6.2 Sun Pharmaceutical Industries Description and Business Overview

6.6.3 Sun Pharmaceutical Industries Sumatriptan Succinate Tablets Sales, Revenue, and Gross Margin (2021–2026)

6.6.4 Sun Pharmaceutical Industries Sumatriptan Succinate Tablets Product Portfolio

6.6.5 Sun Pharmaceutical Industries Recent Developments/Updates

6.7 Simcere Pharmaceutical

6.7.1 Simcere Pharmaceutical Company Information

6.7.2 Simcere Pharmaceutical Description and Business Overview

6.7.3 Simcere Pharmaceutical Sumatriptan Succinate Tablets Sales, Revenue, and Gross Margin (2021–2026)

6.7.4 Simcere Pharmaceutical Sumatriptan Succinate Tablets Product Portfolio

6.7.5 Simcere Pharmaceutical Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Sumatriptan Succinate Tablets Industry Chain Analysis

7.2 Sumatriptan Succinate Tablets Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Sumatriptan Succinate Tablets Production Mode & Process Analysis

7.4 Sumatriptan Succinate Tablets Sales and Marketing

7.4.1 Sumatriptan Succinate Tablets Sales Channels

7.4.2 Sumatriptan Succinate Tablets Distributors

7.5 Sumatriptan Succinate Tablets Customer Analysis

8 Sumatriptan Succinate Tablets Market Dynamics

8.1 Sumatriptan Succinate Tablets Industry Trends

8.2 Sumatriptan Succinate Tablets Market Drivers

8.3 Sumatriptan Succinate Tablets Market Challenges

8.4 Sumatriptan Succinate Tablets Market Restraints

8.5 Impact of U.S. Tariffs

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Dr. Reddy’s Laboratories

Aurobindo Pharma

Teva Pharmaceutical Industries

Viatris

GlaxoSmithKline PLC

Sun Pharmaceutical Industries

Simcere Pharmaceutical

List of Tables

Table 1. Global Sumatriptan Succinate Tablets Market Value by Type (US$ Million), 2025 vs 2032

Table 2. Global Sumatriptan Succinate Tablets Market Value by Regulatory Status (US$ Million), 2025 vs 2032

Table 3. Global Sumatriptan Succinate Tablets Market Value by Application (US$ Million), 2025 vs 2032

Table 4. Global Sumatriptan Succinate Tablets Market Competitive Situation by Manufacturers in 2025

Table 5. Global Sumatriptan Succinate Tablets Sales (K Units) of Key Manufacturers (2021–2026)

Table 6. Global Sumatriptan Succinate Tablets Sales Market Share by Manufacturers (2021–2026)

Table 7. Global Sumatriptan Succinate Tablets Revenue (US$ Million) by Manufacturers (2021–2026)

Table 8. Global Sumatriptan Succinate Tablets Revenue Share by Manufacturers (2021–2026)

Table 9. Global Market Sumatriptan Succinate Tablets Average Price (US$/Unit) of Key Manufacturers (2021–2026)

Table 10. Global Key Players of Sumatriptan Succinate Tablets, Industry Ranking, 2023 vs 2024 vs 2025

Table 11. Global Key Manufacturers of Sumatriptan Succinate Tablets, Manufacturing Sites and Headquarters

Table 12. Global Key Manufacturers of Sumatriptan Succinate Tablets, Product Types and Applications

Table 13. Global Key Manufacturers of Sumatriptan Succinate Tablets, Date of Entry into the Industry

Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 15. Global Sumatriptan Succinate Tablets Companies by Tier (Tier 1, Tier 2, Tier 3), based on Sumatriptan Succinate Tablets Revenue, 2025

Table 16. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 17. Global Sumatriptan Succinate Tablets Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 18. Global Sumatriptan Succinate Tablets Sales by Region (K Units), 2021–2026

Table 19. Global Sumatriptan Succinate Tablets Sales Market Share by Region (2021–2026)

Table 20. Global Sumatriptan Succinate Tablets Sales by Region (K Units), 2027–2032

Table 21. Global Sumatriptan Succinate Tablets Sales Market Share by Region (2027–2032)

Table 22. Global Sumatriptan Succinate Tablets Revenue by Region (US$ Million), 2021–2026

Table 23. Global Sumatriptan Succinate Tablets Revenue Market Share by Region (2021–2026)

Table 24. Global Sumatriptan Succinate Tablets Revenue by Region (US$ Million), 2027–2032

Table 25. Global Sumatriptan Succinate Tablets Revenue Market Share by Region (2027–2032)

Table 26. North America Sumatriptan Succinate Tablets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 27. North America Sumatriptan Succinate Tablets Sales by Country (K Units), 2021–2026

Table 28. North America Sumatriptan Succinate Tablets Sales by Country (K Units), 2027–2032

Table 29. North America Sumatriptan Succinate Tablets Revenue by Country (US$ Million), 2021–2026

Table 30. North America Sumatriptan Succinate Tablets Revenue by Country (US$ Million), 2027–2032

Table 31. Europe Sumatriptan Succinate Tablets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 32. Europe Sumatriptan Succinate Tablets Sales by Country (K Units), 2021–2026

Table 33. Europe Sumatriptan Succinate Tablets Sales by Country (K Units), 2027–2032

Table 34. Europe Sumatriptan Succinate Tablets Revenue by Country (US$ Million), 2021–2026

Table 35. Europe Sumatriptan Succinate Tablets Revenue by Country (US$ Million), 2027–2032

Table 36. Asia Pacific Sumatriptan Succinate Tablets Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)

Table 37. Asia Pacific Sumatriptan Succinate Tablets Sales by Region (K Units), 2021–2026

Table 38. Asia Pacific Sumatriptan Succinate Tablets Sales by Region (K Units), 2027–2032

Table 39. Asia Pacific Sumatriptan Succinate Tablets Revenue by Region (US$ Million), 2021–2026

Table 40. Asia Pacific Sumatriptan Succinate Tablets Revenue by Region (US$ Million), 2027–2032

Table 41. Latin America Sumatriptan Succinate Tablets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 42. Latin America Sumatriptan Succinate Tablets Sales by Country (K Units), 2021–2026

Table 43. Latin America Sumatriptan Succinate Tablets Sales by Country (K Units), 2027–2032

Table 44. Latin America Sumatriptan Succinate Tablets Revenue by Country (US$ Million), 2021–2026

Table 45. Latin America Sumatriptan Succinate Tablets Revenue by Country (US$ Million), 2027–2032

Table 46. Middle East and Africa Sumatriptan Succinate Tablets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 47. Middle East and Africa Sumatriptan Succinate Tablets Sales by Country (K Units), 2021–2026

Table 48. Middle East and Africa Sumatriptan Succinate Tablets Sales by Country (K Units), 2027–2032

Table 49. Middle East and Africa Sumatriptan Succinate Tablets Revenue by Country (US$ Million), 2021–2026

Table 50. Middle East and Africa Sumatriptan Succinate Tablets Revenue by Country (US$ Million), 2027–2032

Table 51. Global Sumatriptan Succinate Tablets Sales (K Units) by Type (2021–2026)

Table 52. Global Sumatriptan Succinate Tablets Sales (K Units) by Type (2027–2032)

Table 53. Global Sumatriptan Succinate Tablets Sales Market Share by Type (2021–2026)

Table 54. Global Sumatriptan Succinate Tablets Sales Market Share by Type (2027–2032)

Table 55. Global Sumatriptan Succinate Tablets Revenue (US$ Million) by Type (2021–2026)

Table 56. Global Sumatriptan Succinate Tablets Revenue (US$ Million) by Type (2027–2032)

Table 57. Global Sumatriptan Succinate Tablets Revenue Market Share by Type (2021–2026)

Table 58. Global Sumatriptan Succinate Tablets Revenue Market Share by Type (2027–2032)

Table 59. Global Sumatriptan Succinate Tablets Price (US$/Unit) by Type (2021–2026)

Table 60. Global Sumatriptan Succinate Tablets Price (US$/Unit) by Type (2027–2032)

Table 61. Global Sumatriptan Succinate Tablets Sales (K Units) by Application (2021–2026)

Table 62. Global Sumatriptan Succinate Tablets Sales (K Units) by Application (2027–2032)

Table 63. Global Sumatriptan Succinate Tablets Sales Market Share by Application (2021–2026)

Table 64. Global Sumatriptan Succinate Tablets Sales Market Share by Application (2027–2032)

Table 65. Global Sumatriptan Succinate Tablets Revenue (US$ Million) by Application (2021–2026)

Table 66. Global Sumatriptan Succinate Tablets Revenue (US$ Million) by Application (2027–2032)

Table 67. Global Sumatriptan Succinate Tablets Revenue Market Share by Application (2021–2026)

Table 68. Global Sumatriptan Succinate Tablets Revenue Market Share by Application (2027–2032)

Table 69. Global Sumatriptan Succinate Tablets Price (US$/Unit) by Application (2021–2026)

Table 70. Global Sumatriptan Succinate Tablets Price (US$/Unit) by Application (2027–2032)

Table 71. Dr Reddy's Laboratories Company Information

Table 72. Dr Reddy's Laboratories Description and Business Overview

Table 73. Dr Reddy's Laboratories Sumatriptan Succinate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 74. Dr Reddy's Laboratories Sumatriptan Succinate Tablets Product

Table 75. Dr Reddy's Laboratories Recent Developments/Updates

Table 76. Aurobindo Pharma Company Information

Table 77. Aurobindo Pharma Description and Business Overview

Table 78. Aurobindo Pharma Sumatriptan Succinate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 79. Aurobindo Pharma Sumatriptan Succinate Tablets Product

Table 80. Aurobindo Pharma Recent Developments/Updates

Table 81. Teva Pharmaceutical Industries Company Information

Table 82. Teva Pharmaceutical Industries Description and Business Overview

Table 83. Teva Pharmaceutical Industries Sumatriptan Succinate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 84. Teva Pharmaceutical Industries Sumatriptan Succinate Tablets Product

Table 85. Teva Pharmaceutical Industries Recent Developments/Updates

Table 86. Viatris Company Information

Table 87. Viatris Description and Business Overview

Table 88. Viatris Sumatriptan Succinate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 89. Viatris Sumatriptan Succinate Tablets Product

Table 90. Viatris Recent Developments/Updates

Table 91. GlaxoSmithKline Company Information

Table 92. GlaxoSmithKline Description and Business Overview

Table 93. GlaxoSmithKline Sumatriptan Succinate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 94. GlaxoSmithKline Sumatriptan Succinate Tablets Product

Table 95. GlaxoSmithKline Recent Developments/Updates

Table 96. Sun Pharmaceutical Industries Company Information

Table 97. Sun Pharmaceutical Industries Description and Business Overview

Table 98. Sun Pharmaceutical Industries Sumatriptan Succinate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 99. Sun Pharmaceutical Industries Sumatriptan Succinate Tablets Product

Table 100. Sun Pharmaceutical Industries Recent Developments/Updates

Table 101. Simcere Pharmaceutical Company Information

Table 102. Simcere Pharmaceutical Description and Business Overview

Table 103. Simcere Pharmaceutical Sumatriptan Succinate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 104. Simcere Pharmaceutical Sumatriptan Succinate Tablets Product

Table 105. Simcere Pharmaceutical Recent Developments/Updates

Table 106. Key Raw Materials Lists

Table 107. Raw Materials Key Suppliers Lists

Table 108. Sumatriptan Succinate Tablets Distributors List

Table 109. Sumatriptan Succinate Tablets Customers List

Table 110. Sumatriptan Succinate Tablets Market Trends

Table 111. Sumatriptan Succinate Tablets Market Drivers

Table 112. Sumatriptan Succinate Tablets Market Challenges

Table 113. Sumatriptan Succinate Tablets Market Restraints

Table 114. Research Programs/Design for This Report

Table 115. Key Data Information from Secondary Sources

Table 116. Key Data Information from Primary Sources

Table 117. Authors List of This Report

List of Figures

Figure 1. Product Picture of Sumatriptan Succinate Tablets

Figure 2. Global Sumatriptan Succinate Tablets Market Value by Type (US$ Million), 2021–2032

Figure 3. Global Sumatriptan Succinate Tablets Market Share by Type: 2025 & 2032

Figure 4. 25 mg Product Picture

Figure 5. 50 mg Product Picture

Figure 6. 100 mg Product Picture

Figure 7. Global Sumatriptan Succinate Tablets Market Value by Regulatory Status (US$ Million), 2021–2032

Figure 8. Global Sumatriptan Succinate Tablets Market Share by Regulatory Status: 2025 vs 2032

Figure 9. Originator Product Product Picture

Figure 10. Generic Product Product Picture

Figure 11. Global Sumatriptan Succinate Tablets Market Value by Application (US$ Million), 2021–2032

Figure 12. Global Sumatriptan Succinate Tablets Market Share by Application: 2025 & 2032

Figure 13. Hospital

Figure 14. Clinic

Figure 15. Others

Figure 16. Global Sumatriptan Succinate Tablets Revenue, (US$ Million), 2021 vs 2025 vs 2032

Figure 17. Global Sumatriptan Succinate Tablets Market Size (US$ Million), 2021–2032

Figure 18. Global Sumatriptan Succinate Tablets Sales (K Units), 2021–2032

Figure 19. Global Sumatriptan Succinate Tablets Average Price (US$/Unit), 2021–2032

Figure 20. Sumatriptan Succinate Tablets Report Years Considered

Figure 21. Sumatriptan Succinate Tablets Sales Share by Manufacturers in 2025

Figure 22. Global Sumatriptan Succinate Tablets Revenue Share by Manufacturers in 2025

Figure 23. Top 5 and Top 10 Global Sumatriptan Succinate Tablets Players: Market Share by Revenue in Sumatriptan Succinate Tablets in 2025

Figure 24. Sumatriptan Succinate Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025

Figure 25. Global Sumatriptan Succinate Tablets Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Figure 26. North America Sumatriptan Succinate Tablets Sales Market Share by Country (2021–2032)

Figure 27. North America Sumatriptan Succinate Tablets Revenue Market Share by Country (2021–2032)

Figure 28. United States Sumatriptan Succinate Tablets Revenue Growth Rate (US$ Million), 2021–2032

Figure 29. Canada Sumatriptan Succinate Tablets Revenue Growth Rate (US$ Million), 2021–2032

Figure 30. Europe Sumatriptan Succinate Tablets Sales Market Share by Country (2021–2032)

Figure 31. Europe Sumatriptan Succinate Tablets Revenue Market Share by Country (2021–2032)

Figure 32. Germany Sumatriptan Succinate Tablets Revenue Growth Rate (US$ Million), 2021–2032

Figure 33. France Sumatriptan Succinate Tablets Revenue Growth Rate (US$ Million), 2021–2032

Figure 34. U.K. Sumatriptan Succinate Tablets Revenue Growth Rate (US$ Million), 2021–2032

Figure 35. Italy Sumatriptan Succinate Tablets Revenue Growth Rate (US$ Million), 2021–2032

Figure 36. Russia Sumatriptan Succinate Tablets Revenue Growth Rate (US$ Million), 2021–2032

Figure 37. Asia Pacific Sumatriptan Succinate Tablets Sales Market Share by Region (2021–2032)

Figure 38. Asia Pacific Sumatriptan Succinate Tablets Revenue Market Share by Region (2021–2032)

Figure 39. China Sumatriptan Succinate Tablets Revenue Growth Rate (US$ Million), 2021–2032

Figure 40. Japan Sumatriptan Succinate Tablets Revenue Growth Rate (US$ Million), 2021–2032

Figure 41. South Korea Sumatriptan Succinate Tablets Revenue Growth Rate (US$ Million), 2021–2032

Figure 42. India Sumatriptan Succinate Tablets Revenue Growth Rate (US$ Million), 2021–2032

Figure 43. Australia Sumatriptan Succinate Tablets Revenue Growth Rate (US$ Million), 2021–2032

Figure 44. China Taiwan Sumatriptan Succinate Tablets Revenue Growth Rate (US$ Million), 2021–2032

Figure 45. Southeast Asia Sumatriptan Succinate Tablets Revenue Growth Rate (US$ Million), 2021–2032

Figure 46. Latin America Sumatriptan Succinate Tablets Sales Market Share by Country (2021–2032)

Figure 47. Latin America Sumatriptan Succinate Tablets Revenue Market Share by Country (2021–2032)

Figure 48. Mexico Sumatriptan Succinate Tablets Revenue Growth Rate (US$ Million), 2021–2032

Figure 49. Brazil Sumatriptan Succinate Tablets Revenue Growth Rate (US$ Million), 2021–2032

Figure 50. Argentina Sumatriptan Succinate Tablets Revenue Growth Rate (US$ Million), 2021–2032

Figure 51. Colombia Sumatriptan Succinate Tablets Revenue Growth Rate (US$ Million), 2021–2032

Figure 52. Middle East and Africa Sumatriptan Succinate Tablets Sales Market Share by Country (2021–2032)

Figure 53. Middle East and Africa Sumatriptan Succinate Tablets Revenue Market Share by Country (2021–2032)

Figure 54. Turkey Sumatriptan Succinate Tablets Revenue Growth Rate (US$ Million), 2021–2032

Figure 55. Saudi Arabia Sumatriptan Succinate Tablets Revenue Growth Rate (US$ Million), 2021–2032

Figure 56. UAE Sumatriptan Succinate Tablets Revenue Growth Rate (US$ Million), 2021–2032

Figure 57. Global Sales Market Share of Sumatriptan Succinate Tablets by Type (2021–2032)

Figure 58. Global Revenue Market Share of Sumatriptan Succinate Tablets by Type (2021–2032)

Figure 59. Global Sumatriptan Succinate Tablets Price (US$/Unit) by Type (2021–2032)

Figure 60. Global Sales Market Share of Sumatriptan Succinate Tablets by Application (2021–2032)

Figure 61. Global Revenue Market Share of Sumatriptan Succinate Tablets by Application (2021–2032)

Figure 62. Global Sumatriptan Succinate Tablets Price (US$/Unit) by Application (2021–2032)

Figure 63. Sumatriptan Succinate Tablets Value Chain

Figure 64. Channels of Distribution (Direct Vs Distribution)

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

Figure 67. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions